News

MaxCyte to Participate in Two Upcoming Investor Conferences

ROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing…

1 year ago

Hisense named first Official Partner of the FIFA Club World Cup 2025™

DUBAI, UAE, Oct. 31, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, announced it has…

1 year ago

Global Times: China’s AI tech brings more convenient, dignified life to people with disabilities and their families

BEIJING, Oct. 31, 2024 /PRNewswire/ -- When Yong Yong (pseudonym) navigates through the bustling exhibition hall, a soothing voice whisperers in…

1 year ago

Amid Rising Costs, XRP Healthcare Prescription Savings Card Making a Difference at 68,000 Pharmacies Across America: A Game-Changer for Individuals and Organizations Alike

DUBAI, UAE, Oct. 31, 2024 /PRNewswire/ -- Amid rising costs in the U.S., the XRP Healthcare Prescription Savings Card is providing…

1 year ago

MGI’s DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024

SHENZHEN, China, Oct. 30, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies…

1 year ago

Fangzhou Inc. Garners Industry Recognition as an Innovator in AI Technology

GUANGZHOU, China, Oct. 30, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou") (06086.HK), a leader in Internet healthcare solutions, was featured on the…

1 year ago

Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement

Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased…

1 year ago

Siemens strengthens leadership in industrial software and AI with acquisition of Altair Engineering

Acquisition of Altair Engineering Inc., a global leader in computational science and artificial intelligence software, strengthens Siemens' position as a…

1 year ago

Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024

Company to host a conference call tomorrow at 8:00 a.m. ET NEWTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Karyopharm Therapeutics…

1 year ago